Encompass Health Surges 4% on Strong Earnings and Strategic Moves Ranks 474th in $250M Volume Rally

On August 5, 2025, Encompass Health (EHC) surged 4.00% with a trading volume of $250 million, a 30.51% increase from the previous day, ranking 474th in market activity. The stock’s rally followed a robust Q2 earnings report and strategic updates.

The company reported Q2 revenue of $1.46 billion, a 12% year-over-year rise, outpacing analyst estimates. Adjusted earnings per share (EPS) reached $1.40, exceeding expectations. Encompass also raised its 2025 guidance, projecting adjusted EPS between $5.12 and $5.34 and full-year revenue of $58.8–$59.8 billion. These results signaled operational strength and reinforced investor confidence.

Encompass further solidified its market position by announcing a $0.19 per share quarterly dividend and plans to build a 40-bed rehabilitation hospital in Tennessee. These moves underscore its commitment to expanding services and returning value to shareholders, aligning with its long-term growth strategy.

A strategy of purchasing the top 500 stocks by daily trading volume and holding for one day achieved a 166.71% return from 2022 to present, outperforming the benchmark’s 29.18% by 137.53%. This highlights the potential of liquidity-driven approaches in capturing short-term market momentum, particularly in volatile environments.